Transoral robotic surgery hypopharyngectomy (TORSH): feasibility and outcomes

Eur Arch Otorhinolaryngol. 2020 Oct;277(10):2883-2892. doi: 10.1007/s00405-020-05984-y. Epub 2020 May 4.

Abstract

Purpose: With the development of minimal invasive procedure, trans-oral robotic surgery (TORS) is expanding in the field of ENT. Most reviews focus on oropharyngeal and laryngeal (supra-glottic) localization. We report here the feasibility and outcomes of TORS hypopharyngectomy (TORSH) for selected patients with hypopharyngeal tumor.

Methods: Between September 2009 and July 2017, 22 patients, retrospectively included, underwent TORSH with curative intent.

Results: From 22 successful hypopharyngectomy, no conversion to open procedure was needed. Three patients (13%) presented a post-operative bleeding and were managed by surgical revision. No fistula was encountered. The 3-year overall survival and disease-specific survival rates were 54 and 92%, respectively. Patients started oral feeding after an average of 7 days. Naso-gastric feeding tubes were removed after a median period of 16 days. Two patients (9%) needed a transient gastrostomy (< 1 year). Three patients (13%) received a transient tracheostomy (< 2 months). Median hospitalization stay was 13 days.

Conclusions: TORSH is a safe technique. Patients' outcomes are favorable and the post-operative morbidity is reduced compared to open neck approach. Hospitalization length and safe swallowing time are reduced.

Keywords: Head and neck tumors; Hypopharynx; Oncology; Robotic surgery; Transoral.

MeSH terms

  • Carcinoma, Squamous Cell*
  • Feasibility Studies
  • Humans
  • Hypopharyngeal Neoplasms*
  • Retrospective Studies
  • Robotic Surgical Procedures*
  • Treatment Outcome